Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 7,313 | 8,704 | 6,140 | 4,160 | 3,908 |
| Operating Income | -7,313 | -8,704 | -6,140 | -4,160 | -3,908 |
| Other Income | -37,270 | -1,456 | -2,028 | 3,747 | 470 |
| Pre-tax Income | -44,583 | -10,160 | -8,168 | -413 | -3,438 |
| Income Tax | 150 | 62 | 38 | 181 | 18 |
| Net Income Continuous | -44,733 | -10,222 | -8,206 | -594 | -3,456 |
| Net Income | $-44,733 | $-10,222 | $-8,206 | $-594 | $-3,456 |
| EPS Basic Total Ops | -18.91 | -6.01 | -4.25 | -0.31 | -1.79 |
| EPS Basic Continuous Ops | -18.91 | -5.30 | -4.25 | -0.31 | -1.79 |
| EPS Diluted Total Ops | -18.91 | -6.01 | -4.25 | -0.31 | -1.79 |
| EPS Diluted Continuous Ops | -18.91 | -5.30 | -4.25 | -0.31 | -1.79 |
| EBITDA(a) | $-7,215 | $-8,532 | $-6,063 | $-4,081 | $-3,837 |